Artificial insemination

Castle Connolly Names 40 Physicians within The Prelude Network® as 2024 Top Doctors

Retrieved on: 
Dienstag, Februar 13, 2024
Fertility preservation, IUI, Education, Reproductive medicine, Physician, Dream, IVF, Parent, Pleasure, Castle Connolly Medical, PGT, NYU, Faculty, Prelude, Vitrification, Artificial insemination, NYU Langone Health, Patient, Genetic testing, Nursing

HOUSTON, Feb. 13, 2024 /PRNewswire/ -- The Prelude Network® (Prelude), the largest and fastest-growing network of fertility providers in North America, today celebrates 40 of its physicians across 14 clinics within its expansive network who are named a 2024 Top Doctor by Castle Connolly.

Key Points: 
  • The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board .
  • Prelude specialists include innovators in fertility care who have pioneered some of today's most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).
  • Dr. Jamie Grifo , Program Director at NYU Langone Fertility and Chief Executive Physician of Inception, was named a 2024 Castle Connolly Top Doctor for the 25th year in a row.
  • "Inception Fertility extends its heartfelt congratulations to our incredible physicians who are so deserving of the Top Doctor recognition," says TJ Farnsworth, Founder and CEO of Inception Fertility.

New fertility research could save time during treatment cycles for those undergoing IUIs

Retrieved on: 
Dienstag, Oktober 17, 2023
Fertility, Artificial insemination, UC, Pregnancy Outcome Prediction study, Physician, Congress, SIS, Research, SGF, Reproductive medicine, Patient, IUI, UC Davis Medical Center, Birth control, Medical device

ROCKVILLE, Md., Oct. 17, 2023 /PRNewswire/ -- New research from Shady Grove Fertility (SGF), a US Fertility practice, assures fertility patients who have undergone a saline-infused sonogram (SIS) that they can proceed with intrauterine insemination (IUI) in the same cycle and expect comparable pregnancy rates as if they had waited for another cycle.

Key Points: 
  • "As one of the only private practice fertility centers in the nation to employ a full-time dedicated research team, our top priority is conducting research that makes a difference in the lives and treatment plans of our patients," shares Phillip A. Romanski, M.D., M.Sc.
  • , fertility specialist at SGF New York and SGF Research Director.
  • "This new study can provide data for our patients that can help them move forward with fertility treatment more quickly in their IUI cycles.
  • We know that fertility treatment is a time commitment, and we can now feel confident about giving time back to our patients with an evidence-based method."

Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution

Retrieved on: 
Montag, September 25, 2023
Artificial insemination, Tubing (recreation), Centers for Disease Control and Prevention, Woman, Infertility, IVF, CDC, ICSI, Diagnosis, FDA, Medical device, Birth control

ATLANTA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced it has received 510(k) Clearance from the United States Food and Drug Administration (FDA) for FemaSeed®, an innovative infertility treatment designed to deliver sperm directly to where conception occurs in a woman’s fallopian tube.

Key Points: 
  • In recent decades, infertility has affected an increasing number of women – estimated at 10 million in the United States according to the Center for Disease Control (CDC).
  • Despite incremental advancements, there have been no recent meaningful affordable options.
  • “We are thrilled to receive 510(k) Clearance from FDA for FemaSeed®, an innovative infertility treatment designed to deliver sperm directly to where conception occurs,” said Kathy Lee-Sepsick, founder, president and chief executive officer of Femasys.
  • The FemaSeed procedure works synergistically with FemVue®, Femasys’ FDA-cleared diagnostic device that enables an in-office ultrasound assessment of the fallopian tubes and serves to provide an infertility diagnosis prior to FemaSeed.

Boston IVF Welcomes Reproductive Endocrinologist Ann Korkidakis, MD to its Waltham & Worcester Fertility Center Teams

Retrieved on: 
Mittwoch, August 23, 2023
Beth Israel Deaconess Medical Center, REI, New England, Telehealth, Male, Pacific coast, ACOG, Artificial insemination, University, American College of Obstetricians and Gynecologists, Embryology, Semen analysis, Queen, Research, Mentorship, IVF, IUI, American Society for Reproductive Medicine, MD, Patient, Laboratory, PCOS, Blood, Fertility, Fellow, McGill University, ASRM, Empathy, Reproductive medicine, American College, Queen's University, Family, Society, Birth control, Mineral oil, Nursing, Obstetrics, Infertility, Gynaecology

WALTHAM, Mass., Aug. 22, 2023 /PRNewswire-PRWeb/ -- Boston IVF, one of the world's most experienced fertility treatment providers, which has assisted in over 150,000 babies born since 1986, is pleased to announce that reproductive endocrinologist, Ann Korkidakis, MD has joined its practice and physician team.

Key Points: 
  • The addition of Dr. Ann Korkidakis to Boston IVF and its Massachusetts fertility centers in Worcester and Waltham bolsters the availability of prompt reproductive care for individuals aspiring to create a family.
  • Dr. Korkidakis is now accepting new patients at all of Boston IVF's fertility centers in Massachusetts via telemedicine and in person at the Worcester and Waltham , Massachusetts locations.
  • Boston IVF's Worcester Fertility Center offers a variety of services, including consultations, intrauterine inseminations (IUI), semen analysis, and blood/ultrasound monitoring.
  • To learn more about Dr. Korkidakis, to receive fertility treatment advice, or to schedule a consultation, visit Boston IVF's website .

Quantum Health Expands Family-Building Offering with Addition of Kindbody

Retrieved on: 
Dienstag, Juli 25, 2023
Managed Care, Other Health, General Health, Professional Services, Family, Consumer, Health Technology, Health Insurance, Parenting, Baby, Maternity, Insurance, Human Resources, Health, Kaiser Family Foundation, Workforce, Male, Partnership, Artificial insemination, Education, EMR, Partner, Infertility, Multimedia, Female, Uday Chopra, IVF, IUI, Fertility preservation, Friction, Patient, Fertility, Menopause, Miscarriage, Genetic testing, News, World Health Organization, Health insurance, Birth control

Quantum Health , the leading consumer healthcare navigation and care coordination company, announced today it has partnered with Kindbody .

Key Points: 
  • Quantum Health , the leading consumer healthcare navigation and care coordination company, announced today it has partnered with Kindbody .
  • Kindbody is a family-building benefits provider offering both virtual care services and access to a network of technology-driven fertility clinics across the country.
  • Kindbody is an additional family-building Preferred Partner™ within Quantum Health’s Comprehensive Care Solutions™ platform.
  • Quantum Health’s navigation and employee engagement platform is powered by their proprietary Real-Time Intercept® model and trusted guidance by Quantum Healthcare Warriors® .

Reproductive Specialists of the Carolinas Welcomes Accomplished Fertility Doctor And Innovator To Practice

Retrieved on: 
Mittwoch, Juni 7, 2023
Yoga, REI, Reproductive medicine, Artificial insemination, Travel, University, American Board of Obstetrics and Gynecology, Education, Friends, Atrium Health, Clinical and Translational Science Award, ART, DRS, Infertility, RSC, Washington University in St. Louis, IVF, IUI, American Board of Commissioners for Foreign Missions, MSCI, Dream, Medical director, Patient, ICTS, Fertility, Furman University, University of Louisville School of Medicine, Gynaecology, Reproductive system, NC, Health, Family, Pacific coast, Medical device, Birth control, Science, Obstetrics

CHARLOTTE, N.C., June 7, 2023 /PRNewswire-PRWeb/ -- Reproductive Specialists of the Carolinas (RSC), a leading fertility practice, is proud to announce that Dr. Ashley Eskew, an award-winning, renowned reproductive endocrinologist and infertility specialist, recently joined this boutique fertility practice as their third doctor. She complements her diverse medical experience with a unique clinical background. Dr. Eskew continues to provide RSC patients with a high level of advanced and inclusive reproductive care.

Key Points: 
  • CHARLOTTE, N.C., June 7, 2023 /PRNewswire-PRWeb/ -- Reproductive Specialists of the Carolinas (RSC), a leading fertility practice, is proud to announce that Dr. Ashley Eskew, an award-winning, renowned reproductive endocrinologist and infertility specialist, recently joined this boutique fertility practice as their third doctor.
  • "Becoming a part of an innovative practice like Reproductive Specialists of the Carolinas, and working alongside Drs.
  • Reproductive Specialists of the Carolinas is located at 1918 Randolph Rd, Ste 410, Charlotte, NC 28207-1109.
  • Dr. Matrika Johnson, Reproductive Specialists of the Carolinas, 1 704-247-2209, [email protected]

Boston IVF Welcomes Reproductive Endocrinologist Dr. Jill Attaman to Expanding New Hampshire Fertility Center Physician Team

Retrieved on: 
Montag, Juni 5, 2023
REI, Artificial insemination, Education, Embryology, Dartmouth College, Ohio State University Wexner Medical Center, IVF, Geisel School of Medicine, Harvard Medical School, IUI, MD, Patient, Division, PCOS, Fertility, Michigan State University, Quality assurance, Gynaecology, University of Washington School of Medicine, Hospital, Empathy, Health, Massachusetts General Hospital, Family, Mineral oil, Birth control, Nursing, Obstetrics, Infertility

BEDFORD, N.H., June 5, 2023 /PRNewswire-PRWeb/ -- Boston IVF, one of the world's most experienced fertility treatment providers, which has assisted in over 150,000 babies born since 1986 and is known for achieving high IVF success rates, is pleased to announce the addition of reproductive endocrinologist, Jill Attaman, MD to its practice and physician team. Dr. Attaman is now accepting new patients at Boston IVF's fertility center in Bedford, New Hampshire.

Key Points: 
  • Dr. Attaman is now accepting new patients at Boston IVF's fertility center in Bedford, New Hampshire.
  • Boston IVF's fertility center in New Hampshire , the only IVF center in the state, hosts a state-of-the-art embryology laboratory, 15,000+ square feet of treatment space, and an enhanced team dedicated to superior patient care.
  • "New Hampshire patients and Boston IVF have gained an accomplished and dedicated reproductive endocrinologist in Dr. Attaman," said David Stern, CEO of the Boston IVF fertility network.
  • To learn more about Dr. Attaman, to receive fertility treatment advice, or to schedule a consultation, visit Boston IVF's website for more information.

Texas Fertility Center Celebrates a Milestone: 25,000 Babies Born

Retrieved on: 
Donnerstag, April 27, 2023
Corpus Christi, Genetic testing, IUI, Cedar Park, Fertility preservation, Artificial insemination, Pregnancy, Fertility, Infertility, MD, Physician, TFC, IVF, Tourism, Birth control, Central Texas

Austin, April 27, 2023 (GLOBE NEWSWIRE) -- This Mother’s Day, Texas Fertility Center (TFC) celebrates an important milestone reached in January: Since its founding in 1980 by Thomas Vaughn, MD, the fertility care practice has helped to bring 25,000 babies into the world.

Key Points: 
  • Austin, April 27, 2023 (GLOBE NEWSWIRE) -- This Mother’s Day, Texas Fertility Center (TFC) celebrates an important milestone reached in January: Since its founding in 1980 by Thomas Vaughn, MD, the fertility care practice has helped to bring 25,000 babies into the world.
  • Offering state-of-the-art fertility diagnostics and treatment to couples struggling to conceive, TFC is home to 10 renowned board certified fertility specialists, with another joining the group in August 2023.
  • TFC provides the complete range of fertility services, including fertility evaluations and infertility treatments such as intrauterine insemination (IUI) and IVF.
  • To learn more about Texas Fertility Center, visit www.txfertility.com, or call (512) 451-0149 to schedule a consultation.

Ohio Reproductive Medicine Becomes the Only Fertility Center in Columbus to Be Recognized in Newsweek Magazine's 2023 America's Best Fertility Clinics Report

Retrieved on: 
Montag, April 17, 2023
Male, Partnership, Artificial insemination, Gender identity, Marital status, PGT, Newsweek, Fertility clinic, System, Infertility, ART, History, Doctor of Philosophy, IVF, IUI, Fertility, ORM, Patient, Emil Steinberger (endocrinologist), Family, Mineral oil, Birth control, COLUMBUS, MD

COLUMBUS, Ohio, April 17, 2023 /PRNewswire-PRWeb/ -- Ohio Reproductive Medicine (ORM), the first-ever fertility center in Columbus, is pleased to announce that it has been recognized for outstanding care in Newsweek Magazine's 2023 America's Best Fertility Clinics report.

Key Points: 
  • The Newsweek recognition strengthens Ohio Reproductive Medicine's standing as a world class fertility center in Columbus for treatments including IVF, IUI, egg freezing, and more.
  • COLUMBUS, Ohio, April 17, 2023 /PRNewswire-PRWeb/ -- Ohio Reproductive Medicine (ORM), the first-ever fertility center in Columbus , is pleased to announce that it has been recognized for outstanding care in Newsweek Magazine's 2023 America's Best Fertility Clinics report.
  • Ohio Reproductive Medicine is the only fertility center in Columbus to be recognized – and one of only two IVF clinics to be acknowledged in Ohio.
  • In 2021, Ohio Reproductive Medicine opened the doors to its new 15,000 square foot fertility center and IVF laboratory in Columbus.

Boston IVF Fertility Network Recognized in Newsweek Magazine 2023 America's Best Fertility Clinics Report

Retrieved on: 
Montag, April 3, 2023
Male, Artificial insemination, Newsweek, ART, Infertility, Boston, MBA, Fertility clinic, IVF, IUI, Fertility, Roe v. Wade, Patient, Physician, Risk, Nursing, Birth control

WALTHAM, Mass., April 3, 2023 /PRNewswire-PRWeb/ -- Boston IVF, one of the world's most experienced fertility treatment networks, is pleased to announce that five of its centers across New England, New York, and the Midwest have been recognized for outstanding care in Newsweek Magazine's 2023 America's Best Fertility Clinics report.

Key Points: 
  • View the complete America's Best Fertility Clinics report by Newsweek.
  • The prestigious recognition is based on a national survey of over 3,000 reproductive endocrinologists, infertility specialists, obstetricians, and gynecologists who refer patients to fertility clinics.
  • The report also analyzes key performance indicator metrics for assisted reproductive technology (ART) – including clinic accreditations, patient reviews, and more.
  • "Boston IVF's sole mission is to deliver world-class, reproductive care to the communities throughout our fertility network," said Boston IVF CEO David Stern, MBA.